Belong – Beating Cancer Together

The world’s largest social and professional network for managing and navigating treatment journeys

Free and anonymous for cancer patients and caregivers

Belong – Beating Cancer Together

The world’s largest social and professional network for managing and navigating treatment journeys

Free and anonymous for cancer patients and caregivers

Our
Our
Mission

Improving patient quality of life & quality of care worldwide,
through technology, services, data and AI

Belong News

A New CAR-T Cell Therapy

The FDA has recently approved a new treatment indication for CAR-T cell therapy, Yescarta (axicabtagene ciloleucel). The treatment is now approved for patients with large B-cell lymphoma

Read More
Belong app logo
Beating Cancer Together

The world’s largest social
& professional network
for cancer patients

A Glance at Our Features

Direct Chats with World-Renowned Experts example - Belong.life

Direct Chats with World-Renowned Experts

Leading experts address questions asked by both patients and caregivers in various professional groups, including: oncology, radiology, researchers, doctors in various fields and experts in allied disciplines who provide patients with reliable and educational information.

A Supportive & Interactive Patient Community

An attentive and supportive social network of patients and caregivers tailored to each patient’s and their specific needs, interests, concerns and passions.
The forums provide assistance and support: users share their personal experiences, tips and information. They support one another through coping with daily challenges, recovery and the many other facets of the journey.

A Supportive & Interactive Patient Community example - belong.life

Care Plan and Treatment Management

Leading experts address questions asked by both patients and caregivers in various professional groups, including: oncologist, radiologic, doctors in different fields, researchers, allied disciplines and other experts who provide patients with reliable information & education.

Digital Medical & Knowledge Center Binder

There is no need to carry a huge binder! All your medical records are organized digitally in one place and can be shared privately with family members, friends, and medical professionals.

Digital Medical & Knowledge Center Binder in Belong.life app
Personalized content, updates and news flashes in Belong.life app

Personalized Content, Updates and News Flashes

Breakthrough artificial intelligence (AI), machine learning (ML) and big data capabilities enable personalized content and updates as well as treatment navigation tools that provide tips and reminders every step of the way.

Clinical Trial Matching Service

Belong’s matching features uses machine learning and clinical trial-specific NLP algorithms to analyse and notify users of available & relevant clinical trials around the globe.

Clinical trial matching service in Belong.life app

Our Experts

Dr. Eyal Morag
Dr. Eyal Morag
Neurologist

Chairman of Radiology
Belong group – Ask the Imaging Expert
Dr. Eyal Morag, M.D., Chairman of Radiology at the Assuta Ashdod Medical Center. Graduated from Boston University School of Medicine in Boston, MA. He interned in medicine at Brockton Hospital, Brockton, MA. Dr. Eyal Morag completed his Radiology residency at Harvard Medical School, where he also received fellowship training in cardiovascular and interventional radiology. He then joined private practice in Western MA where he served as Chief of Radiology for several years. He then moved to Toledo, Ohio where he was the Regional Radiology Director for Mercy Health Hospitals. Dr. Eyal Morag is certified by the American Board of Radiology.

Dr. Eli Sapir
Dr. Eli Sapir
Neurologist

Radiotherapy Oncologist
Belong group – Ask the Radiation Oncologist
Dr. Eli Sapir,Chairman at the Samson Assuta Ashdod University Hospital, Israeli Board Certified Radiation Oncologist, with a resume of a clinical and research fellowship at the Radiation Oncology Department of the University of Michigan, Ann Arbor. A member of the American Society for Therapeutic Radiology and Oncology (ASTRO), as well as the American Society for Clinical Oncology (ASCO). Dr. Eli Sapir personal interest and research are dedicated to head and neck tumors as well as gastrointestinal tumors, including stereotactic body radiotherapy of primary and secondary liver lesions.

Hani Steinberg
Hani Steinberg
Melanoma Nurse


Belong group – Melanoma MD
Hani Steinberg, a registered nurse for many years and for the last 10 years,she is the coordinator nurse at the Melanoma and Immunotherapy Unit at the Oncology Department at HMC. She started her professional experience as an Operating Room nurse and later as the Head Nurse. Hani Steinberg professionalized as a transplant coordinator for liver and kidney.

Dr. Ravit Geva
Dr. Ravit Geva
Neurologist

Medical Oncologist
Belong group – Colo-Rectal Cancer MD, Neuro Endocrine Tumors MD
Dr. Ravit Geva is a medical oncologist specializing in GIT malignancies and clinical trials. She graduated medical school with honors at the Ben-Gurion University and followed by a residency in Medical oncology in the Tel-Aviv Sourasky Medical center. Dr. Geva did a fellowship in GIT malignancies under the guidance of prof. Eric Van Cutsem in the Clinical Digestive Oncology Department in Leuven, Belgium. She further specialized in the development of investigational drugs and clinical trials in Oxford University where she did her MSc in Experimental Therapeutics. Dr. Geva heads the Gastrointestinal Malignancies Center as well as the Oncology Research Unit at the Tel-Aviv Sourasky medical center in Israel. She is the chair of CTrials, The Israeli Association for Research and the Advancement of the Biomedical Community.

Dr ido laskov
Dr. Ido Laskov
Neurologist

Gynecologic Oncologist
Belong group – Ask the Gyne-oncologist
Dr. Ido Laskov completed 6 years of residency in Obstetrics & Gynecology at the Tel Aviv Sourasky Medical Center and then completed a 3-year research & clinical sub-specialty in Gynecologic Oncology at the McGill University in Montreal, Canada. His training includes medical management of women with gynecological malignancies and he specializes in performing complex oncologic surgeries including pelvic, abdominal, laparoscopic and robotic surgeries. His research interests are in novel therapeutic interventions in women’s cancers for which he was able to publish a number of papers and has presented at national and international meetings. Currently Dr. Ido Laskov is the Deputy director of the Gynecologic Oncology department at the Tel Aviv Sourasky Medical Center.

Dr.Adrian Duak - Belong Life
Dr. Adrian Duak
Deputy Director of Hematology Institute University Hospital Assuta Ashdod


Belong group – Ask the Hemato-Oncologist group In Spanish
Dr. Adrian Duak completed his MD studies in 1992 in Buenos Aires, Argentina. Currently, He is specialist in Internal Medicine and Hematology both in Argentina and Israel. In 2009-2013 I completed a fellowship program on Myeloproliferative Neoplasms (MPNs) at the Department of Biomedicine, at the University of Basel, Switzerland. Subsequently, He joined the Hematology Institute of the Sheba Medical Center. There he worked as a senior hematologist treating in both hospitalized and outpatient clinics. Since January 2019, he is part of the Hematology Institute at the University Hospital Assuta where he is also in charge of the MPN and acute leukemia service, and responsible for the hospitalized patients. He mainly treat patients suffering from entities, such as Polycythemia Vera, Essential Thrombocytemia, Myelofibrosis, Chronic Myelogenous Leukemia, Hypereosinophilic syndrome, Mastocytosis, and others

Prof. Irit Avivi

Head of Hematology Division at Tel-Aviv Sourasky Medical Center
Belong group – Ask the Hemato-oncologist
Prof. Irit Avivi is the Head of the Hematology Division at the Tel-Aviv Sourasky Medical Center and a Senior Lecturer at the Faculty of Medicine at the Technion Institute of Technology. She completed her MD with honors at the Technion, internship, residency and fellowship at the Rambam Medical Center and postgraduate fellowship at the Hematology Dep. at the University College London Hospitals, London, UK and became Senior attending physician responsible for the Lymphoma and Myeloma Service at the Dep. of Hematology at the Rambam Medical Center. Prof. Avivi has been involved in many clinical trials and scientific meetings and achieved several research accomplishments. She published many scientific publications. Prof. Avivi is a member of many professional associations worldwide.

Dr. Eytan Ben Ami
Dr. Eytan Ben Ami

Medical Oncologist
Belong group – Sarcoma MD
Dr. Eytan Ben-Ami completed medical oncology residency at the Chaim Sheba Medical Center in 2015. Between 2015-2018 he worked as a research scholar in the department for sarcoma and bone oncology at the Dana-Farber Cancer Institute in Boston, where he focused his research on investigational therapies in patient derived xenograft models (PDX) in mice, as well as the potential of targeted therapies in the various sarcoma subtypes. Dr. Eytan Ben-Ami clinical focus is on the multidisciplinary and treatment approach to localized and advanced soft-tissue and bone sarcomas in adults.

Prof Michal Lotem
Prof Michal Lotem

Medical Oncologist
Belong group – Melanoma MD
Prof. Michal Lotem is the head of the Melanoma and Immunotherapy Unit at the Hadassah Medical Center. Prof. Lotem participated in pivotal clinical trials that led to FDA’s approvals and is conducting anti-cancer vaccination protocols. Most recent is the use of engineered cancer cells with improved properties of activating immune cells. Prof. Lotem graduated at the Sackler School of Medicine, Tel Aviv University, has a Board Certification in Dermatology and Clinical and Radiation Oncology. She conducted her post-doctoral research fellowship at NCI, Bethesda, MD and is a visiting professor at Ronald Levy’s lab, pioneer of Monoclonal antibody-based lymphoma therapy and cancer immunotherapy, Stanford, CA. Prof. Lotem’s belief is that researcher clinicians should be the motivating force to guide scientific research to meet the acute needs of developing and advancing cancer cure.

Dr. Maya Gottfried
Dr. Maya Gottfried

Director of the Oncology Institute at the Meir Medical Centre
Belong group – Lung Cancer MD
Dr Maya Gottfried is the Director of the Oncology Institute at the Meir Medical Centre and a Senior Lecturer at the Tel Aviv School of Medicine. She completed her MD at the University of Padua, Italy and became a Senior Specialist in Internal Medicine at the Meir Medical Centre and later Chief Resident in the Oncology Department at Sheba Medical Centre and Instructor of Internal Medicine at the Tel Aviv School of Medicine. She completed a Fellowship in Medical Oncology at the Institute of Oncology Gustave-Roussy, in France, before returning as Chief Resident to the Oncology Department of Sheba Medical Centre and Meir Medical Centre. Dr Gottfried was appointed Senior Specialist in Oncology and Radiation at the Sheba and Meir Medical Centres, and later as Head of the Lung Oncology Unit at the Meir Medical Centre. Dr Gottfried has been involved extensively in clinical trials on non-small cell lung cancer acting as Principal Investigator. She is a member of many associations worldwide.

Dr. Ron Lavy
Dr. Ron Lavy

Head of Surgery B at the Assaf Harofeh Medical Center
Belong group – Surgical Oncology MD
Dr. Ron Lavy is the Head of Surgery B at the Assaf Harofeh Medical Center, Israel. He received his MD degree from Tel Aviv Sackler school of Medicine and completed residency training at Assaf Harofeh. Dr. Lavy completed his 2 years fellowship in the Dep. of Surgical Oncology at the University of Illinois, Chicago, before returning as a senior general surgery to Assaf Harofeh. Dr. Lavy has been involved in the publications of many professional papers and is a member in the Israeli Medical Association, Surgical Association, Israel society of Surgical Oncology and the Israel society of Colorectal Surgery.

Dr. Avivit Peer - Belong Life
Dr. Avivit Peer
Head of the Urinary Cancer Clinic at Rambam Medical Center


Belong group – Kidney & Bladder Cancer MD
Dr. Avivit Peer is a senior doctor at the Oncology Division at Rambam Medical Center, in charge of the kidney and urinary cancer clinic, and heads the oncology clinical trial unit. She graduated life science studies and med school with honors and specialized in oncology at the Rambam Medical Center. She studied the field of clinical trials in France and testicular cancer in the US. She lectures at the medical faculty of the Technion Institute, and received several recognition awards for her activity in medical education. She is a member in several oncology associations in Israel and the US. Alongside patient treatment and clinical trials, Dr. Peer’s center of activity is the development of oncology clinical trial methods, including research into groundbreaking cancer drugs and early stage drug effect on cancer patients and its effect on new drug development.

Dr. Tzahala Tzuk-Shina
Dr. Tzahala Tzuk-Shina

Director of the Neuro-Oncology Clinic
Belong group – Brain & Nervous Sys. Cancer MD
I am the Neuro-oncological Division Director at the Rambam Medical Center. I completed my MD degree at the Technion Haifa and became a senior specialist in neurology at Carmel, Lady Davis hospital. I did my fellowship in Neuro-Oncology at the Hadassah Medical Center. In 1994 I founded the Neuro-Oncology Clinic at the Rambam Medical Center and been The Head of the service since then. My main occupations are treatment of patients with brain and central nervous system tumors, as well as cancer and treatment related neurological complications. I am involved extensively in clinical trials on brain tumors acting as principal investigator.

Prof. Aron Popovtzer
Prof. Aron Popovtzer
Head, Sharett institute of Oncology

Belong group – Head & Neck Cancers MD
Prof. Aron Popovtzer graduated from Hebrew University, School of Medicine and completed his residency in Otolaryngology and H&N Surgery in Rabin Medical Center, followed by residencies in both Medical and Radiation oncology which he completed in the Davidoff Cancer center. He completed a two year fellowship in Head and neck cancer in the University of Michigan Ann Arbor and Brachytherapy Fellowship in Memorial Sloan Kettering NYC. Prof. Popovtzer is Head of the Sharett institute of Oncology, ENT, Medical & radiation oncologist specialist. Prof. Popovtzer is also the Chairman of the Israel Head and Neck Society, and an active member in the American Head and Neck Society and the EORTC. He has published over 60 papers and is an associate clinical Professor in the Tel Aviv University. His research focuses on tailored medicine for radiosentization genomic sequencing in unusual carcinomas and highly conformal irradiation of head and neck cancer.

Dr. Daniel Vorobiof,Chief Medical Director at Belong.Life
Dr. Daniel A. Vorobiof
Chief Medical Director, Belong

Belong group – Ask the Oncologist
Dr. Daniel A. Vorobiof founder of the Sandton Oncology Centre in Johannesburg, South Africa since 1989 until 2018. Dr. Daniel A. Vorobiof completed his MD degree from the University of Cordoba, Argentina, and a Doctor in Medicine degree from the University of Pretoria, South Africa. He have been working in Medical Oncology since 1980, a member of several national and international oncologic societies. Currently he is a member of the European School of Oncology (ESO) Core Faculty in Breast Cancer and Malignant Melanoma. He is also on the Editorial Board of various international oncologic medical journals and the editor of 2 magazines.He was a founder member and a chairman of several South African Medical Oncology Societies, He had been involved in clinical research nationally and internationally and published more than 100 research articles in medical oncology journals.

Dr. Ronit Elhasid
Dr. Ronit Elhasid
Head of the Pediatric hemato-oncology unit

Belong group – Children Oncology MD
Dr. Ronit Elhasid Head of the Pediatric hemato-oncology and bone marrow transplant department at the Tel Aviv Sourasky Medical Center, since 2011. Dr. Ronit Elhasid has been treating children with Leukemia and those undergoing stem cell transplants for over two decades. Since 2014, she is serving as the head of the national protocol for ALL relapse during childhood which is part of the international protocol. Throughout the years, she has been taking part in dozens of clinical trials and participating in multiple professional associations, worldwide. Dr. Ronit Elhasid his a senior lecturer at the Sackler Faculty of Medicine.

Dr. Moshe Gatt
Dr. Moshe Gatt
Head of Hematology Division at Hadassah MC

Belong group – Ask th Hemato-oncologist
Dr. Moshe Gatt the Head of the Hematology Division at the Hadassah Hebrew University MC.He completed MD studies in 1999, his Internal Medicine residency in 2004 and Hematology fellowship in 2007. In 2007-2009 Dr. Moshe Gatt completed a scientific fellowship at The Jerome Lipper center for Multiple Myeloma, at the Dana Farber Cancer Institute, Harvard Medical School, Boston, MA. Subsequently. Dr. Moshe Gatt personal and scientific interest is in Myeloma and Amyloidosis,and he is chairman of the Israeli Multiple Myeloma study group. He is a member of the Israeli and the American Societies of Hematology.

Dr. Luba Vasilenko
Dr. Luba Vasilenko
Head of the Intermediate Cardiac Care Unit

Belong group – Cardio-Oncology MD
Dr. Luba Vasilenko, Head of the Intermediate Cardiac Care Unit and the chairman of the Cardio-Oncologic Clinic at the Assuta Ashdod Medical Center. Dr. Luba Vasilenko completed his MD degree at the Altaisk Medical Royal University in Russia. He completed his internal medicine residence at the Sheba Medical Center and the cardiology residence at the Hillel Yaffe Medical Center.He has more than ten years of experience as a cardiologist and have been working in Cardio-Oncologic clinics since 2014. I published several papers and am involved in several clinical trials. Dr. Luba Vasilenko is active member of the European Cardiology Society.

Dr. Ofer Purim
Dr. Ofer Purim
Chief of the GI Malignancy Service

Belong group – Stomach & Esophageal Cancer MD
Dr. Ofer Purim is the Chief of the gastrointestinal malignancy service at the new Assuta University Hospital. He graduated with honors at the Szeged University in Hungary, completed his residency at the Davidoff Cancer Center at the Beilinson Hospital and worked as a senior physician at the Davidoff center in the gastrointestinal unit. Dr. Purim specializes in treatment of rare tumors of the GI tract such as GIST and neuroendocrine tumors and has over 14 years of experience in the field. Dr. Purim is very active in researches and served as a primary investigator and sub investigator in dozens of local and international trials. He has published 32 manuscripts in his field and is a lecturer to physicians, nurses and for the public. Dr. Purim is a member of the Executive Committee of the Israeli Society for Oncology and Radiotherapy.

Yael S. Coord
Yael S. Coord
Oncology Coordinator and Inating Nurse

Belong group – Immunotherapy Oncologist
Yael S. Coord inating Nurse certified nurse (RN, BA) MA in public health and epidemiology. she has been working at the Sheba Medical Center, for the past eight years. She started her career as a research nurse, managing care of melanoma patients during early clinical development and registration trials of current standard of care immunotherapy drugs. As immunotherapy became the backbone treatment for melanoma (as well as other diseases),she transitioned her role in recent years to coordinating nurse, it includes patient education, management of immunotherapy drug-related toxicities, follow-up for any clinical or treatment related issues, during and after cessation of active treatments. Her goal is to assist patients, maintain their daily routines through their treatments and afterwards. Whether through coordination of care by the medical team, addressing immunotherapy related issues, or being available for patients’ needs. She consider preservation of the patients’ quality of life my highest priority.

Dr. Naama Halpern
Dr. Naama Halpern
Senior Medical Oncologist

Belong group – Liver & Bile Duct Cancer MD
Dr. Halpern is a senior medical oncologist at Sheba Medical center. Dr. Halpern graduated medical school and completed her residency at the Hebrew University- Hadassah Medical center. Dr. Halpern is the head of the oncology residency program at Sheba. Her clinical work and research includes gastrointestinal malignancies, focusing on young onset and genetic background of cancer. She is leading the program for young cancer patients at Sheba, aiming to better understand the causes and characteristics of these tumors while improving patient care.

Dr. Osher Esther
Dr. Osher Esther
Head of Neuroendocrine Tumor unit

Belong group – Neuro Endocrine Tumors MD
Dr. Esther Osher, is the head of the neuroendocrine tumor unit at the Institute of Endocrinology , Tel Aviv Souraski Medical Center(TASMC). Graduated medical School, at the Technicon Haifa, and PhD degree at Sackler Faculty of Medicine, Tel -Aviv University. She is a specialist in Internal medicine and Endocrinology since 2002, since then she is a senior physician at the institute of endocrinology at TASMC. Dr. Osher is a member in several medical associations in Israel and worldwide, published medical papers and a lectures at the Sackler School of Medicine TAU.

Dr. Daniel Keizman
Dr. Daniel Keizman
Head of Genitourinary Oncology Unit

Belong group – Prostate & Testicular Can. MD
Dr. Daniel Keizman, is the head of the Genitourinary Oncology Unit, at the Division of Oncology, at the Tel-Aviv Sourasky Medical Center, Israel. Dr Keizman graduated from the Sackler Faculty of Medicine, Tel Aviv University. He is board certified in internal medicine and medical Oncology (trained at the Tel-Aviv Sourasky Medical Center). He did his post doctoral clinical fellowship in genitourinary oncology during the years 2008-2001 at the Kimmel Cancer Center, Johns Hopkins Hospital, Baltimore, USA. Dr Keizman’s current research activity, focuses on genitourinary oncology. He is the author of numerous studies and review articles published in medical journals, and presented numerous studies in international meetings. He is a member of the American Society of Clinical Oncology and the Israel Society of Clinical Oncology

Dr. Yair Peled
Dr. Yair Peled
Senior Doctor, Pediatric Hemato-Oncology

Belong group – Children Oncology MD
Yair Peled. a senior doctor at the pediatric hemato-oncology and bone marrow transplant department at the Tel Aviv Sourasky medical center.Dr. Yair Peled treat pediatric patients that suffer from solid tumors and mainly sarcomas. He graduated from medical school at the Hebrew University, completed his residency in pediatrics at Sha’arei Tzedek medical center, and graduated pediatric hematology and oncology residency at the Hadassah medical center.

Dr. Daliah Tsoref
Senior Oncologist

Belong group – Ovarian Cancer MD
Dr Daliah Tsoref studied medicine at Cambridge University and University College Hospital, London. She completed a 6 year residency in Medical and Radiation Oncology at the Hadassah Medical Center, Jerusalem. Subsequently she undertook a three year fellowship in medical gynecologic oncology and palliative care at the Princess Margaret Hospital, Toronto, Canada where she was mentored by Professor Amit Oza, world renowned in the treatment and research of ovarian cancer. She works as a senior oncologist at the Davidoff Institute, Beilinson campus focusing on gynecologic and breast cancer with a special interest in ovarian cancer and BRCA related disease.

Prof. Danny Rosin
Prof. Danny Rosin
Senior surgeon at Sheba Medical Center

Belong group – Surgical Breast Cancer MD
Prof. Danny Rosin finished his medical studies, with distinction, at Tel Aviv University. He completed his surgical residency at the Sheba Medical Center, including a year of training at the Mount Sinai Medical Center in New York. After becoming attending surgeon, he completed an 18 months fellowship in minimally invasive surgery at the Cleveland Clinic in Florida. For the last 18 years Prof. Rosin has been a senior surgeon in the department of general surgery and transplantations at Sheba Medical Center, and practices a wide variety of general surgery procedures, including breast surgery, hernia surgery, colon cancer operations and various advanced laparoscopic procedures. Prof. Rosin was awarded twice as outstanding physician. He is currently the deputy-manager of the department of surgery, and the head of the department of ambulatory surgery.

Dr. Tomer Charas
Dr. Tomer Charas
Head of Genitourinary Oncology unit

Belong group – Prostate & Testicular Can. MD, Kidney & Bladder Cancer MD
Dr. Tomer Charas, heads the Genitourinary oncology unit at the Oncology Division at the Rambam Health Care Campus, Haifa, Israel. He is a board-certified radiation oncologist, specializing in radiation therapy treatments of the genitourinary tract cancers. He graduated from Semmelweis University medical school, Budapest, Hungary with honors. After completing his radiation oncology residency training at Rambam Health Care Campus, He completed radiation oncology Genitourinary fellowship program and additionally Brachytherapy fellowship program, both at Memorial Sloan Kettering Cancer Center NYC, NY. He’s involved in prostate brachytherapy (implanting radioactive sources in the prostate – a minimally invasive procedure), SBRT (highly focused radiotherapy treatments), researching and implementing new technologies aiming to improve patients’ care and reduce side effects from treatments. Dr. Charas is a member of the EORTC, ABS and Amercian Society for Radiation Oncology (ASTRO).

Dr. Roy Mano
Dr. Roy Mano
Senior Urologist

Belong group – Kidney & Bladder Cancer MD
Dr. Roy Mano serves as an attending physician in the Urology Department at Tel-Aviv Sourasky Medical Center. He is a board certified urologist focused on the treatment of patients with urologic malignancies including bladder, kidney and prostate cancers. Dr. Mano received his medical degree from The Ruth & Bruce Rappaport Faculty of Medicine at the Technion – Israel Institute of Technology where he graduated with honors. After finishing the Urology residency training program at Rabin Medical Center, he completed a two year Society of Urologic Oncology fellowship at Memorial Sloan Cancer Center in New York. During his fellowship he trained in both open and robotic surgeries for the treatment of urologic malignancies. In addition to his clinical duties Dr. Mano is involved in clinical and translational research focused on bladder and kidney cancer, with the aim of improving our ability to personalize treatment options for patients diagnosed with cancers involving the genito-urinary tract

Prof. Shahar Frenkel
Prof. Shahar Frenkel
Head of Ocular Oncology

Belong group – Eye Cancers
Prof. Shahar Frenkel is a clinician-scientist, an Ocular Oncologist and Ophthalmic Pathologist, and the head of the Ocular Oncology Laboratory at the Hadassah-Hebrew University Medical Center. He is a graduate of the Hebrew University in Jerusalem’s MD-PhD program. He was trained at Hadassah, Jerusalem, Israel, and at UIC, Chicago, IL, USA. Prof. Frenkel served on the board of the International Society of Ocular Oncology and is currently on the board of the Israeli Society for Vision and Eye Research. Prof. Frenkel diagnoses and treats any kind of eye cancer, he developed surgical techniques for the treatment of eye cancers, and he is striving to develop new biological therapies for cancer. Prof. Frenkel is the consulting Ophthalmologist for clinical trials for a variety of cancers.

Justine Friedman
Justine Friedman
Clinical Dietician

Belong group – Diet, Nutrition & Cancer
Justine Friedman a clinical dietician licensed in South Africa and Israel. Justine Friedman has been in practise for over 20 years. She is passionate about guiding people towards living a life with improved energy, health and vitality through nutrition education, personalised meal plans and guiding them to shift how they think and feel about their lives and bodies. This holistic approach has proven beneficial as different people have individual needs based on their chronic illness and life situation. One of the keys on a path of healing from cancer is to nourish one’s body as optimally as possible to reduce side effects of the disease and treatment process and halt or reverse the concerns of loss of lean muscle, inflammation and loss of appetite and taste which leads to lower immunity, fatigue and loss of quality of life.

Lizzie Rubin
Lizzie Rubin
Sex Therapist

Belong group – Sexuality & Cancer
Lizzie Rubin, I am a registered nurse, AASECT-certified sex therapist and cancer survivor. She switched fields years ago to become a sex therapist when a terminal oncology patient of her asked if he could make love to his wife when he went home for the weekend. In her mind, she had three questions: Why no one ever taught me this in nursing school? Why didn’t the doctors talk to him about it? And finally, is this what cancer patients think about — sex?? In a split second, she answered, “of course you may”, he was smiling from ear to ear.

Users
Are Our
#1
Priority
Belong Cancer
Brenda D.

I love that everyone is so open and honest with their experiences. I also like that there are professionals to ask questions to.

Belong Cancer
Cynthia S.

I have found great resources with this app. You can ask questions from professional and clinicians and get wonderful feedback. They will keep you informed about new clinical trials and everyone in the discussions
are sensitive and caring.

Belong Cancer
Debra G.

A very good site. full of information and answers to your fears and worries about cancer.

Belong Cancer
Jennifer C.I.M

Cancer is really a scary thing. To have this kind of support and hope is vital to healing

Belong Cancer
Kristin L.

Exceptional! Love it!

Belong Cancer
Linda R.

Very helpful App. I have learned so much from others here.

Belong Cancer
Victoria M.

It’s awesome to be able to have your questions answered by other people going through the same thing as you are and having the option to ask a doctor as well.

Belong Cancer
Herbyka Y.

So grateful to have an application such as Belong that connects and helps people to manage and live with Cancer.

Belong Cancer
Cookie F.

Belong is a great app. Helped me through my journey for sure. So many great people with great advice and suggestions. Awesome group.

Belong.Life – Meaningful Patient Care & Community Platforms

The creator of social and professional networks for managing and navigating various diseases and patient journeys.
The company’s mission is to improve quality of life and quality of care for patients around the world through technology, engagement, data and AI.

Skip to content